Opko Health (OPK) Capital Leases (2019 - 2026)

Opko Health (OPK) has 7 years of Capital Leases data on file, last reported at $2.7 million in Q2 2026.

• Quarterly Capital Leases fell 28.03% year-over-year to $2.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.7 million (down 28.03% YoY) and the FY2025 annual result came in at $3.4 million, down 16.49% from the prior year.
• Capital Leases slipped to $2.7 million in Q2 2026, from $3.0 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $7.7 million in Q3 2023 to a low of $2.7 million in Q2 2026.
• A 5-year average of $4.8 million and a median of $4.3 million in 2024 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2023 — Capital Leases increased 2.61% — and 2024, when it tumbled 44.13%.
• Tracing OPK's Capital Leases over 5 years: stood at $7.1 million in 2022, then increased by 2.61% to $7.3 million in 2023, then tumbled by 44.13% to $4.1 million in 2024, then slipped by 16.49% to $3.4 million in 2025, then slipped by 21.77% to $2.7 million in 2026.
• The last three Capital Leases figures came in at $2.7 million (Q2 2026), $3.0 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.